Work

Two phase 3 placebo-controlled trials of aztreonam lysine for inhalation (AZLI) for non-cystic fibrosis bronchiectasis (NCFB)

Year: 2013

Type: conference-abstract

Source: European Respiratory Journal

DOI: 10.1183/13993003/erj.42.suppl_57.p4136

Authors: Alan Barker, Anne O'Donnell, Philip J. Thompson, Patrick Flume, Jonathan Ruzi, Javier de Gracia, Wim Boersma, Eva Polverino, Lixin Shao, Jenny Zhang, Sheila Leitzinger, Laura Haas, Matt McKevitt, A. Bruce Montgomery, Alexandra Quittner, David Gossage, Thomas O'Riordan

Institutions: Oregon Health & Science University, Georgetown University Medical Center, Sir Charles Gairdner Hospital, Medical University of South Carolina, Vall d'Hebron Hospital Universitari, Medisch Centrum Alkmaar, Hospital Clínic de Barcelona, Gilead Sciences (United States), University of Miami

Language: English

Topic: Cystic Fibrosis Research Advances

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W1895676417

Cites:

Cited by: 14

Related to: 10